Bio

Li He is co-head of our practice in Asia (excluding Japan). A leading adviser to companies in Greater China and across Asia, he has deep experience guiding companies through their most critical milestones, from pre-IPO financing through listing and beyond. Over the past two decades, Li advised on more than 50 U.S. IPOs and more than 60 HKEX IPOs, including some of Asia’s most important, complex and groundbreaking deals – approximately 50 of which have won “Best IPO of the Year” awards. He is particularly noted for his understanding of key verticals, from technology to healthcare and pharma to financial institutions. This knowledge can make the difference in resolving the thorniest structural, regulatory and disclosure challenges facing issuers. Asian Legal Business cites Li’s "deep insights, outstanding skills, and extensive experience." In 2020, he was named the "IPO Lawyer of the Year" at the Asia Legal Awards and the "Dealmaker of the Year - International" at the ALB China Law Awards.